Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) carriers are known to develop pulmonary complications characterized by T-lymphocytic alveolitis. The aim of this study was to determine the profile and role of soluble Fas (sFas) and sFas ligand (sFasL) in the lung of asymptomatic HTLV-1 carriers. We measured sFas and sFasL levels in serum and bronchoalveolar… (More)

Topics

Cite this paper

@article{Sakamoto2004SolubleFO, title={Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.}, author={Noriho Sakamoto and Hiroshi Mukae and Takeshi Fujii and Tomoyuki Kakugawa and Hideyuki Kaida and Jun-ichi Kadota and Shigeru Kohno}, journal={Respiratory medicine}, year={2004}, volume={98 3}, pages={213-9} }